Florbetaben-PET detects cardiac amyloidosis

November 4, 2016

Australian researchers have shown the proficiency of PET with the radiotracer F-18 florbetaben to detect abnormal deposits of proteins in the heart in a study published in the November issue of The Journal of Nuclear Medicine.

Called cardiac amyloidosis, the condition is particularly difficult to diagnose because the first signs are nonspecific and usually attributed to other causes. Patient prognosis is extremely poor as the condition is often discovered late in the course of the disease.

Read the full article.